Trial Details

COMPLETED
Basic Information
Clinical ID c3026
Identifier NCT02621892
Trial Title A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Constipation Predominant Irritable Bowel Syndrome
Interventions DRUG: Tenapanor|DRUG: Placebo
Participant Information
Sponsor Ardelyx
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2015-10
Primary Completion Date 2017-03
Completion Date 2017-04